Sickle Hemoglobin
Showing 1 - 25 of 2,616
Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
- Sickle Cell Disease
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2023
Sickle Cell Disease Trial in Boston (Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA
Recruiting
- Sickle Cell Disease
- Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA targeting BCL11a
-
Los Angeles, California
- +8 more
Jan 10, 2023
Sickle Cell Disease, Sickle Beta Zero Thalassemia, Sickle B+ Thalassemia Trial in Chicago (MED-Go App)
Recruiting
- Sickle Cell Disease
- +3 more
- MED-Go App
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hospital of Chicago
Mar 7, 2022
Sickle Cell Disease Trial in Groningen (GBT021601)
Active, not recruiting
- Sickle Cell Disease
-
Groningen, NetherlandsICON Clinical Research Unit
Jan 30, 2023
Sickle Cell Disease Trial in Boston (BEAM-101)
Not yet recruiting
- Sickle Cell Disease
- BEAM-101
-
Boston, MassachusettsBoston Children's Hospital
Jul 11, 2022
Hemoglobin SC Disease, Anemia, Sickle Cell Trial in Miami (Parent Educational Support)
Completed
- Hemoglobin SC Disease
- Anemia, Sickle Cell
- Parent Educational Support
-
Miami, FloridaMailman Center for Child Development
Jul 26, 2021
Sickle Cell Hemoglobin C Disease, Hemoglobin S Disease Trial in France (Training Program)
Completed
- Sickle Cell Hemoglobin C Disease
- Hemoglobin S Disease
- Training Program
-
Bobigny, France
- +8 more
Sep 6, 2021
Sickle Cell Disease, Sickle B+ Thalassemia, Sickle Beta Zero Thalassemia Trial in Chicago (HU-Go app)
Completed
- Sickle Cell Disease
- +3 more
- HU-Go app
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hospital of Chicago
Jul 27, 2021
HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia Trial in Austria, Germany (TCRa/ß+ and CD19+ depleted haploidentical stem
Recruiting
- HbS Disease
- +5 more
- TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation
- Matched sibling donor transplantation
-
Düsseldorf, Germany
- +4 more
Jul 29, 2021
Sickle Cell Disease, Sickle Cell Hemoglobin C, Sickle Beta Zero Thalassemia Trial in Chicago (PROs assessment using sickle cell
Completed
- Sickle Cell Disease
- +3 more
- PROs assessment using sickle cell disease mobile app (SCD-app)
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Dec 17, 2020
Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)
Study of a Deformability Parameter of Red Blood Cell
Not yet recruiting
- Drepanocytosis
- basal blood collection
- +2 more
- (no location specified)
May 10, 2023
Physical Function in Sickle Cell Patients Taking Voxelotor
Not yet recruiting
- Sickle Cell Disease
-
Falls Church, VirginiaInova Schar Cancer Institute
Sep 1, 2023
VO2max & HRQoL in Children With Sickle Cell Disease
Completed
- Sickle Cell
- Children
-
Montpellier, Occitanie, FrancePediatric and Congenital Cardiology Department, Arnaud De Villen
Aug 16, 2023
Sickle Cell Anemia in Children Trial in Omdurman (Acacia Senegal extract, Pectin)
Unknown status
- Sickle Cell Anemia in Children
- Acacia Senegal extract
- Pectin
-
Omdurman, Khartoum, SudanMilitary Hospital
Jan 26, 2020
Sickle Cell Disease, Sickle Cell Trait, Beta-Thalassemia Trial (High performance liquid chromatography, Automated sickling test,
Not yet recruiting
- Sickle Cell Disease
- +4 more
- High performance liquid chromatography
- +5 more
- (no location specified)
Aug 17, 2022
Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)
Recruiting
- Sickle Cell Disease
- OTQ923
-
Los Angeles, California
- +4 more
Jan 9, 2023
Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia
Not yet recruiting
- Sickle Cell Disease, Beta Thalassemia Intermedia
- RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
- (no location specified)
May 30, 2023
Sickle Cell Disease Trial (Plant-based omega-3-FA)
Not yet recruiting
- Sickle Cell Disease
- Plant-based omega-3-FA
- (no location specified)
Mar 6, 2023
Sickle Cell Anemia, Hemoglobinopathy, Thalassemia Trial in Houston (Campath -1H, Dilantin, Busulfan)
Terminated
- Sickle Cell Anemia
- +2 more
- Campath -1H
- +3 more
-
Houston, Texas
- +1 more
Jan 15, 2020
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022